Influenza IMPRINT Cohort: Defining the Impact of Initial Influenza Exposure on Immunity in Infants

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

1500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-10-17

Study Completion Date

2028-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary aim is to define the immune responses to the infant's initial influenza exposure (vaccine or infection) and how that affects the immune response to subsequent influenza exposures

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Development of Childhood Anti-Influenza Immunity

NCT03673345

Influenza Influenza Immunisation

COMPLETED PHASE4

Natural History of Systemic and Nasal Mucosal Immunity After Influenza Vaccination in a Pediatric Population

NCT04963166

Influenza Immunity

COMPLETED

Kinetics of the Immune Response to Inactivated Influenza Vaccine in Healthy Adults

NCT03743688

Influenza Influenza, Human Vaccine Reaction +4 more

COMPLETED

Influenza Vaccine in Premature Infants

NCT00455169

Influenza Infant, Premature

COMPLETED

CT18 Infant Influenza Priming Study in Vaccine Naive Infants

NCT03669627

Influenza

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Vaccination is a leading public health intervention for reducing morbidity and mortality from influenza worldwide. Vaccine optimization is hampered by lack of understanding the natural history of infection and immunity, including the full complement of maternal immunity imparted to infants. This gap in understanding can be addressed only through a well-designed birth cohort study. Up to 1500 mother-infant pairs will be enrolled at or after week 34 in pregnancy over three flu seasons, up to four years of age depending on birth month, at two sites. Follow-up will occur from the third trimester until the child is three to four years of age, along with medical records review to ascertain outcomes not captured through weekly illness and respiratory surveillance, and medical record review up to 18 years of age. The primary aim is to rigorously document the natural history of infection and immune response to influenza in study infants for at least three entire flu seasons.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Influenza

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cincinnati IMPRINT birth cohort

mother-infant pairs enrolled at or after week 34 in pregnancy and followed over three flu seasons, up to four years of age.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Mother pregnant and ≥ 34 weeks gestation and ≥ 18 yrs. of age
* Plans to deliver at local hospital
* Lives within designated home zip codes:
* No plans to move outside study area within study timeframe
* Cell phone that can be used for text messaging
* Singleton live born infant, born ≥ 34 weeks gestational age (GA)

Exclusion Criteria

* Fetal or infant death prior to maternal hospital discharge
* Mother known to be infected with HIV based on medical records
* Major congenital anomalies, prenatally diagnosed or other major disorder or anomaly as determined by the PI
* Reported use of heroin, cocaine or methamphetamines during pregnancy
* Adoptive infant
* Enrolled in any investigational vaccine trial or other interventional randomized, clinical trial involving the mother or infant that the PI's deem to be in conflict with study outcomes

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes